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Cocaine Enhances HIV-1 Infectivity in Monocyte Derived
Dendritic Cells by Suppressing microRNA-155
Jessica Napuri1, Sudheesh Pilakka-Kanthikeel1,2,3, Andrea Raymond1,2, Marisela Agudelo1,2,
Adriana Yndart-Arias1,2,3, Shailendra K. Saxena4, Madhavan Nair1,2,3*
1 Department of Immunology, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, United States of America, 2 Institute of
NeuroImmune Pharmacology, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, United States of America, 3 Center for Personalized
Nanomedicine, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida, United States of America, 4 CSIR-Centre for Cellular & Molecular
Biology, Hyderabad, India

Abstract
Cocaine and other drugs of abuse increase HIV-induced immunopathogenesis; and neurobiological mechanisms of cocaine
addiction implicate a key role for microRNAs (miRNAs), single-stranded non-coding RNAs that regulate gene expression and
defend against viruses. In fact, HIV defends against miRNAs by actively suppressing the expression of polycistronic miRNA
cluster miRNA-17/92, which encodes miRNAs including miR-20a. IFN-g production by natural killer cells is regulated by miR155 and this miRNA is also critical to dendritic cell (DC) maturation. However, the impact of cocaine on miR-155 expression
and subsequent HIV replication is unknown. We examined the impact of cocaine on two miRNAs, miR-20a and miR-155,
which are integral to HIV replication, and immune activation. Using miRNA isolation and analysis, RNA interference,
quantitative real time PCR, and reporter assays we explored the effects of cocaine on miR-155 and miR-20 in the context of
HIV infection. Here we demonstrate using monocyte-derived dendritic cells (MDCCs) that cocaine significantly inhibited
miR-155 and miR-20a expression in a dose dependent manner. Cocaine and HIV synergized to lower miR-155 and miR-20a
in MDDCs by 90%. Cocaine treatment elevated LTR-mediated transcription and PU.1 levels in MDCCs. But in context of HIV
infection, PU.1 was reduced in MDDCs regardless of cocaine presence. Cocaine increased DC-SIGN and and decreased CD83
expression in MDDC, respectively. Overall, we show that cocaine inhibited miR-155 and prevented maturation of MDDCs;
potentially, resulting in increased susceptibility to HIV-1. Our findings could lead to the development of novel miRNA-based
therapeutic strategies targeting HIV infected cocaine abusers.
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to HIV-1 latency [10–12]. HIV-1 actively suppresses the
polycistronic miRNA cluster miR-17/92 [10], which encodes
miR-17-(5p/3p), miR-18, miR-19a, miR20a, miR19b-1 and miR92-1 [13], facilitating efficient viral replication [10]. Further
studies have shown that over expression of miR-155 downregulates DC-SIGN [14], which plays a major role in HIV
infection [15] independent of CD4 and/or co-receptors [16–18].
Since, previous studies have shown that HIV actively suppresses
the polycistronic cluster, encoding miR-20a, and miR-155, we
chose to examine these two miRNAs in the context of HIV
infection and drug abuse [10,19,20]. It is important to point out
that the effects of cocaine on the expression of miR-155 and -20a
have not been clearly investigated yet. Here, we demonstrate that
cocaine modulates miR–155 and -20a in the context of HIV
infection.
PU.1, a transcription factor [21], is required for the generation
and maturation of most myeloid lineages such as macrophages,
neutrophils and dendritic cells [22,23]. PU.1, a direct transcription
factor of DC-SIGN and a target of miR-155, regulates DC-SIGN
in a reciprocal fashion [24,25]. Additionally, PU.1 has been shown
to regulate HIV-1 transcription by physically interacting with the

Introduction
Despite thirty years of research efforts, over 34 million people
are living with Human Immunodeficiency Virus (HIV) today. In
the last decade, we observed an entangled epidemic of HIV and
drugs of abuse. Cocaine, one of the most widely abused drugs in
the United States, has been shown to exacerbate HIV disease
progression and HIV-associated neurocognitive disorders (HAND)
[1–3]. Previously we reported that cocaine promotes HIV-1
replication through the induction of Dendritic Cell-Specific
Intercellular adhesion molecule-3-Grabbing Non-integrin (DCSIGN) expression [4]. However, the mechanism of cocaineinduced DC-SIGN modulation and HIV infectivity is not clear.
MicroRNAs (miRNA), small non-coding, single stranded RNA
molecules of 19–25 nucleotides, have recently emerged as a major
class of gene expression modulators [5]. miRNAs regulate gene
expression by targeting the 39-UTR (untranslated regions) of
specific mRNAs for degradation or translational repression,
thereby controlling protein production [6] and regulating cellular
pathways. It has been shown that certain miRNA negatively
regulate HIV-1 replication [7–9]. In fact, altered miRNA
expression in HIV-infected subjects has been shown to contribute
PLOS ONE | www.plosone.org
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NF-kB subunits within the LTR [26]. Given the impact of miR155 on PU.1 and subsequently on DC-SIGN [21] we hypothesize
that cocaine suppresses miR-155 and 20a thereby increasing DCSIGN expression and promoting HIV-1 replication. Our results
show that cocaine down- regulates miR-155 and miR-20a and
modulates DC-SIGN, DC maturation, and HIV infectivity.

Cytotoxicity
XTT assay (ATCC.org) was performed on MDDCs according
to manufacturer’s instructions. Briefly, 200 ml of cell suspension
and 100 ml of XTT-PMS was plated per well in a 96 well plate and
incubated for 4 hours. The cytotoxicity was measured by ELISA
reader. The absorbance was measured at 450 nm with l
correction at 595 nm and correlated with control values [33].
The results are expressed as percentage of live cells.

Materials and Methods
Cell culture

Plasmids, transfections, and reporter assays

MDDC were differentiated from peripheral blood mononuclear
cells (PBMC) as described previously [27–31]. Briefly, PBMC
separated on a density gradient were incubated at 37uC in RPMI1640 media containing 10% fetal bovine serum. Non-adherent
cells were removed after 1 hr, and adherent cells were cultured for
6 days in media containing 100 U/ml of recombinant human
GM-CSF and IL-4 (R & D systems, USA). Media were changed
and cytokines were replenished every 48 hrs. At day 6, MDDCs
were removed by gently splashing the surface. DC maturation was
induced by culturing with the same cytokine mixtures in the
presence of LPS (100 ng/ml) for additional 2 days.

The following plasmids were obtained through the NIH AIDS
Reagent Program, Division of AIDS, NIAID, NIH: pHIVCAT(cat#2619) from Dr. Gary Nabel and Dr. Neil Perkins,
pSVTat (cat#294) from Dr. Alan Frankel, pNL4-3Luc.R-E-(cat#3418) Dr. Nathaniel Landau, Aaron Diamond
AIDS Research Center, The Rockefeller University, pHEFVSV-G from Dr. Lung-Ji Chang. Amphoteric HIV pseudoviruses
containing the firefly luciferase gene were produced by transfecting
293T cells with pHEF-VSV-G (10 mg) and pNL4-3.Luc.R-E(10 mg) in 90 mm culture dishes. Briefly, plasmid DNA was diluted
in Opti-MEM serum free media (Invitrogen). Lipofectamine LTX
& PLUS reagent (Invitrogen) diluted in equal volume and added to
diluted DNA at a 1:1 ratio. Mixture was incubated for 5 minutes
to allow formation of DNA-liposome complexes. Culture supernatants containing the pseudoviruses were collected 72 hours posttransfection and clarified by centrifugation at 400 g. Pseudoviruses
were competent for single round of replication. Luciferase
production measured as described below. HEK293T cells were
seeded at 56105 cells in a 6-well culture dish, transfected (using
Lipofectamine LTX) with pLTR-CAT (8 mg) alone or in
combination with pSVTat (0.8 mg) in the presence of cocaine.
Cocaine was added to cells 24 hours post transfection, and
cultured for an additional 48 hours. Cells were harvested 72 hours
post-transfection, lysed, and CAT concentration was measured via
ELISA using Chloramphenicol acetyl-transferase (CAT) kit
(Roche). Protocols performed according to manufacturer’s instructions. Absorbance was measured at 405 nm (Synergy HT,
BioHIT). Results were normalized to total protein concentration
of samples as measured by BioRad Protein Assay (BioRad
Laboratories).

MicroRNA Analysis
MDDCs were treated with cocaine at (0.1 mM, 1 mM, 10 mM)
for 15 hrs and 24 hrs. Total RNA was isolated using the mir-Vana
miRNA Isolation (Ambion, USA), in accordance with manufacturer’s protocol. 2 ng of each RNA sample were used for
quantitative real-time RT-PCR (qRT-PCR), performed using
the TaqMan MicroRNA Reverse Transcription Kit, PCR Master
Mix, and specific primers (Applied Biosystems, USA). Primer
sequences were; miR-155 - (UUAAUGCUAAUCGUGAUAGGGGU) and miR-20a - (UAAAGUGCUUAUAGUGCAGGUAG). All reactions were analyzed using Step One RealTime PCR System (Applied Biosystems). miRNA levels were
normalized to U6 snRNA control and the cycle threshold (Ct)
values were calculated as previously described [32].

Infection of MDDCs with HIV-1BAL
MDDCs were infected with HIV-1BAL, (NIH AIDS Research
and Reference Reagent Program; catalog no. 510) at a concentration of HIV-1 p24 20 ng/106cells for 2 hr as previously
described [31], followed by washing to remove unbound virus.
HIV-1 infected and uninfected MDDCs were cultured in the
presence/absence of cocaine (1 mM) for 7 days. The culture
supernatants were quantitated for p24 antigen.

Luciferase Assay
Luciferase concentration in whole cell lysates from cells infected
with HIV-luciferase pseudovirus (20 ng) in presence/absence of
cocaine was determined using a Luciferase assay system
(Promega), according to manufacturer’s instructions (Technical
Bulletin #TB281). Briefly, cells infected with the HIV-luciferase
pseudovirus (20 ng) were harvested three days post infection (dpi),
washed with PBS and lysed. Lysates were pre-cleared by
centrifugation at 12,000 g for 2 minutes at 4uC. 100 ml of
luciferase assay reagent were dispensed in a 96 well microplate
(Costar), 20 ml of cell lysate added to each well, mixed by
pipetting, and read on a luminometer (Synergy HT, BioHIT).

miR-155 transfection in MDCCs
MDDCs were transfected with a miR-155 mimic or anti-miR155 using a standardized siRNA transfection protocol (Santa Cruz
Biotechnology) at a final concentration of 75 nM. Following
transfection, MDDCs were treated with cocaine (1 mM) and/or
infected withHIV-1.

Real Time RT-PCR Analysis
miR-155 mimic/anti-miR-155 transfected MDDCs were treated with or without cocaine and/or HIV-1. After respective
treatments, cells were harvested and RNA was isolated using
RNAeasy mini kit (Qiagen, Germany). The cDNA was synthesized
using the high-capacity reverse transcriptase cDNA kit to perform
qRT-PCR by Taqman gene expression assay using specific
primers for PU.1 and (LTR)-R/U5. (primers for (LTR)-R/U5:
59-primer, 59-TCTCTCTGGTTAGACCAGATCTG; 39-primer,
59-ACTGCTAGAGATTTTCCACACTG. Values were normalized against GAPDH.
PLOS ONE | www.plosone.org

Flow cytometry
Following respective treatments (transfection/cocaine) MDDCs
and Mature DCs (MDCs) were harvested, washed with FACS
buffer and incubated with Fc blocking reagent for 10 min at 4uC.
Cells were stained for 30 min in the dark at RT with CD83 PE
(BD Pharmingen) and DC-SIGN FITC (eBiosciences) or with
appropriate isotype controls. Cells were acquired using FACS
Calibur with collection of 100,000 cells and analyzed using Flowjo
software.
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we infected MDDCs with a HIV-luciferase pseudo virus (capable
of only single-round replication) in the presence or absence of
cocaine (Fig. 2C). Viral transcription increased almost 30-fold in
cocaine-treated MDDCs, compared to the infected MDDCs not
exposed to cocaine. ‘The observed cocaine-mediated effect on
HIV replication and transcription could also in part be due to
increased infectivity of the pseudotyped HIV-luciferase virus.’
Together, these results suggested that cocaine exposure enhanced
HIV-1 transcription and that increased viral production in
cocaine-treated MDDCs may be associated with the downregulation of miR-155 and 20a.

Statistical analysis
Results are presented as mean 6 SE of three independent
experiments. Differences between treated and untreated cultures
were compared by Student’s t-Test. Comparisons of more than
two groups were made using analysis of variance (ANOVA)
(Kruskal-Wallis). Data were analyzed using Graphpad Prism
version 5.0 software and statistical significance considered when pvalue#0.05.

Results
Cocaine Down-regulates miR-155 and 20a Expression in
MDDCs

Increased miR-155 expression Inhibits HIV-1 Replication
To further investigate the exact role(s) of miR-155 on cocaine
mediated modulation of HIV-1 replication, we transfected
MDDCs with either miR-155 mimic or anti-miR-155, followed
by infection with HIV-1 and/or cocaine treatment. Total RNA
was extracted and amplified by qRT-PCR for HIV-1 LTR/R-U5
[31,39,40]. miR-155 over expression significantly suppressed HIV1 replication whereas anti-miR-155 transfection in combination
with HIV-1 infection enhanced HIV-1 replication compared to
non-transfected HIV-1 control (Fig. 3). MDDCs transfected with
miR-155 mimic and infected with HIV-1 in the presence of
cocaine significantly down-regulated HIV-LTR-R/U5 (Data not
shown), whereas MDDCs transfected with anti-miR-155 and
infected with HIV-1 in the presence of cocaine significantly upregulated HIV-LTR-R/U5, compared to cocaine-treated cells
transfected with the negative control (Fig. 3). These results suggest
that MDDCs become more susceptible to HIV infection, when
miR-155 is inhibited.

Cocaine is known to increase the risk of acquiring HIVinfection and exacerbate the progression of HIV-associated
neurological disorders [34–36]. MiR-155, a crucial molecule in
the regulation of immune cell functions, [37] is shown to be
increased during DC maturation and suppressed by HIV [38].
miR-20a is also reported to be suppressed by HIV [10]. Since
cocaine has been shown to impact miR expression, we examined
the effect of cocaine on miR-155 and -20a. MDDC (16106 cells/
ml) were cultured for 15 and 24 hrs with different concentrations
(0.1 mM -10 mM) of cocaine. Cocaine significantly down-regulated
the expression of miR-155 in a dose-dependent manner at 15 hr
(Fig. 1A). At 24 hr, cocaine produced even greater suppression of
miR-155 gene expression, compared to 15 hr treatment (Fig. 1A).
Similar to miR-155, expression of miR-20a was also significantly
inhibited by cocaine in a dose dependent fashion at 15 hr,
compared to untreated control (Fig. 1B). At 24 hr, cocaine
produced greater suppression of miR-20a, similar to miR-155
(Fig. 1B). Based on our observations, a cocaine concentration of
1 mM was used in subsequent studies.

Over-expression miR-155 down-regulates PU.1
PU.1 has been reported to be a direct transcription factor of
miR-155, and has been indirectly linked to regulate DC-SIGN
expression [14,21]. To better understand the mechanism of
cocaine-induced modulation of HIV replication, we investigated
the effects of miR-155 on the regulation of PU.1, by transfection
experiments. Over-expression of miR-155 suppressed PU.1
expression, while blocking miR-155 expression enhanced PU.1
expression, compared to non-targeting control (Fig 4). MDDCs
transfected with miR-155 mimic and treated with cocaine
decreased PU.1 expression whereas anti-miR-155 transfection
and subsequent cocaine treatment increased PU.1 expression,
compared to non-targeting cocaine control (Fig. 4). Overexpression of miR-155 followed by HIV-1 infection showed a
down-regulation in PU.1 expression whereas transfection with
anti-miR-155 showed an up-regulation, compared to non-targeting HIV-1 control. Decreased PU.1 expression was observed with
miR-155 over-expression, followed by HIV-1 infection and
cocaine treatment, whereas an up-regulation was seen with antimiR-155 transfection, compared to respective non-targeting
control. Non-targeting cocaine control increased PU.1 expression,
compared to negative control. PU.1 expression in the HIVinfected control is decreased almost 28% when compared to the
uninfected control. Interestingly, cocaine increased PU.1 in
control miRNA while HIV infection decreased PU.1. We
observed no significant difference in PU.1 expression from
uninfected control.

Cocaine Treatment Does Not Induce Cytotoxicity
To ensure that observed down-regulation was not due to nonspecific toxicity induced by cocaine, MDDCs were cultured with
cocaine at different concentrations (0.1 mM, 1 mM, 10 mM), and
cell cytotoxicity was measured by XTT assay as described [33].
Cocaine at 0.1–10 mM did not cause any toxicity, compared to
controls (Fig. 1C).

Cocaine and HIV-1 synergistically suppress miR-155 and
miR-20a
Previous studies have shown that HIV-1 suppresses certain
miRNAs during virus replication [10]. We investigated whether
cocaine and HIV-1 synergize to modulate miR-155 and 20a.
MDDC were infected with HIV-1(20 ng) and treated with/
without cocaine for 4 days. HIV-1 significantly suppressed both
miRNAs compared to untreated control (Fig. 1D), and HIV-1 in
combination with cocaine showed a synergistic effect on miRNA
expression. We examined whether the cocaine-induced downregulation of miR-155 and -20a is associated with concomitant upregulation of HIV transcription and p24 production. We found, as
measured by p24 ELISA, an almost 3-fold up-regulation in HIV
production with cocaine exposure (Fig. 2A), suggesting that
cocaine may significantly impact HIV transcription. To verify
cocaine-mediated effects on transcriptional activation, we used a
HIV-LTR-CAT reporter. Cells were transfected with pSVTat and
pHIV-LTR-CAT, treated with cocaine for 48 hrs (24 hr post the
initial LTR-CAT transfection), harvested after three days post
transfection, and assessed for CAT concentration. We observed
that cocaine increased HIV transcription by 5-fold (Fig. 2B). To
further verify long-term effects of cocaine on HIV transcription,
PLOS ONE | www.plosone.org

miR-155Cocaine enhances miR-155 mediated DC-SIGN
upregulation
DC-SIGN facilitates HIV-1 infection independent of CD4 and/
or co-receptors [16–18]. Previous studies have shown miR-155
3
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Figure 1. Cocaine and HIV synergistically down-regulate miR-155 and 20a. MDDCs (16106 cells/ml) from normal donors were cultured with
3 different concentrations (0.1, 1 and 10 mM) of cocaine for 15 and 24 hrs.Total cellular microRNA was extracted and amplified by specific RT-PCR for
miR-155 and 20a gene expression. Cocaine down regulates (A) miR-155 (B) and 20a gene expression. (C) Cocaine treatment does not induce
cytotoxicity. Cell suspension (200 ml) was subjected to XTT-PMS (100 ml) followed by a 4 hr incubation period. Cytotoxicity was measured by ELISA
reader and cell suppression was calculated by: suppression index (%) = ((Abs cocaine – Abs blank)/(Abs control - Abs blank))6100%. (D) MDDCs
(1610 cells/ml) from normal donors were infected with HIV-1BAL at a concentration of 20 ng for 2 hr, followed by treatment 6 cocaine (1 mM) for 7
days. Total cellular microRNA was extracted and amplified by specific RT-PCR for miR-155 and 20a gene expression. Results shown are representative
of mean 6 SEM of three experiments. Graphs are represented as % of TAI compared to the non-treated control. p-value#0.05 were considered to be
significant.
doi:10.1371/journal.pone.0083682.g001

PLOS ONE | www.plosone.org
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Figure 2. HIV replication increased in MDDCs treated with cocaine. (A) MDDCs (16106 cells/ml) from normal donors were infected with HIV1BAL at a concentration of 20 ng for 2 hr, followed by treatment 6 cocaine (1 mM) for 7 days. The culture supernatants were quantitated for p24 Ag.
Significance is calculated with respect to HIV-1 treated control cells. (B) Effect of cocaine on HIV-1 transcription was determined using an LTR-CAT
reporter data normalized to total protein concentration. (C) HIV-1 transcription was determined in MDDCs from normal donors infected with HIVluciferase viruses competent for a single round of infection (,20 ng per (16106 cells) in the presence/absence of cocaine (1 mM) for 72 hours.
Cultures were harvested 72 hours post infection and luciferase assayed. Results shown are representative of mean 6 SEM of three experiments.
p-value#0.05 were considered to be significant.
doi:10.1371/journal.pone.0083682.g002

Figure 4. miR-155 modulates PU.1 levels. MDDCs (16106 cells/ml)
from normal donors were transfected with anti-miR-155, at a final
concentration of 75 nM, followed by infection with HIV-1 (20 ng) and
treatment 6 cocaine (1 mM). Total RNA was extracted and amplified by
RT-PCR for PU.1 gene expression. Values were normalized against
GAPDH and significance is calculated with respect to control. Graphs
are represented as % difference from control. Results shown are
representative of mean 6 SEM of three experiments. p-value#0.05
were considered to be significant.
doi:10.1371/journal.pone.0083682.g004

Figure 3. miR-155 inhibition enhances HIV-1 replication. MDDCs
(16106 cells/ml) from normal donors were transfected with anti-miR155, at a final concentration of 75 nM, followed by infection with HIV-1
(20 ng) and treatment 6 cocaine (1 mM). Total RNA was extracted and
amplified by RT-PCR for HIV-1 LTR/RU-5 gene, to detect early steps in
HIV reverse transcription. Significance is calculated with respect to non
targeting HIV-1 control cells. Graphs are represented as % difference
from control. Results shown are representative of mean 6 SEM of three
experiments. p-value#0.05 were considered to be significant.
doi:10.1371/journal.pone.0083682.g003

PLOS ONE | www.plosone.org
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Figure 5. Cocaine increases DC-SIGN expression and prevents DC maturation by down regulating miR-155. (A–B) MDDCs at Day 6
were transfected with anti-miR-155 or anti-miR-Control, at a final concentration of 75 nM, followed by treatment with or without cocaine (1 mM) for 3
days. Non-transfected, untreated cultures served as controls. Cells were stained with antibody against DC-SIGN and the membrane expression was
assessed by flow cytometry and presented as graphs showing percentage of positive population (%). (C–D) Following transfection and treatment
with or without cocaine, LPS (100 ng/mL; for DC maturation) was added to all wells and left for 2 days. At the end of treatment, cells were stained
with antibody against CD83 (DC maturation marker) and was assessed by flow cytometry. Representative graphs show percentage of positive
population (%). (E) Over-expression of miR-155 does not cause cytotoxicity in MDDC. Cell suspension (200 ml) was subjected to XTT-PMS (100 ml)
followed by a 4 hr incubation period. Cytotoxicity was measured by ELISA reader and cell suppression was calculated by: suppression index (%) =
(Abs cocaine – Abs blank)/(Abs control - Abs blank))6100%.
doi:10.1371/journal.pone.0083682.g005

presence of cocaine significantly enhanced DC-SIGN (Fig 5A–
B). These findings suggest that cocaine mediated up-regulation of
DC-SIGN is through suppression of miR-155.

expression down-regulated DC-SIGN expression [21]. Our lab
has reported that cocaine up-regulates DC-SIGN expression on
MDDCs [31]. We hypothesize that cocaine regulates DC-SIGN
expression through miR-155 down regulation. To explore this
hypothesis we examined the effect of cocaine on DC-SIGN
expression. MDDCs were transfected with a miR-155 inhibitor in
the presence/absence of cocaine and DC-SIGN expression was
monitored by flow cytometry. Results show that cocaine increased
the percentage of DC-SIGN positive cells by 2-fold compared to
untreated cells (Fig. 5A). This is consistent with previous findings
[31]. Similar to cocaine-treatment, miR-155 inhibition also
increased DC-SIGN, whereas the negative control miRNA did
not have any effect. Moreover, miR-155 inhibition, in the

PLOS ONE | www.plosone.org

Cocaine impairs maturation of MDDCs
miR-155 has been reported to be up-regulated during DC
maturation. Given the role of miR-155 in DC maturation, we
examined the impact of cocaine on DC maturation. Since our
previous experiments showed that cocaine down-regulated miR155, we wanted to determine whether DC maturation was
impaired by cocaine. To test this, MDDCs were transfected with
either a miR-155 inhibitor or a negative control miRNA.
Maturation of MDDCs was induced by adding LPS to the culture
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Figure 6. Overview of Cocaine-enhancement of HIV infectivity in MDC via the down-regulation of miR-155. (A) In absence of cocaine
or HIV miR155 targets DC-SIGN and PU.1, reducing the expression post-transcriptionally. Lowered PU.1 and DC-SIGN expression is observed in mature
DCs. (B) In the presence of Cocaine or HIV alone miR-155 levels are reduced resulting in elevated PU.1 and DC-SIGN expression. This phenotype is
evident in immature DCs (iDCs). Together HIV and cocaine, synergize to dramatically lower miR-155 resulting in elevated levels of the transcription
factor Pu.1. In turn, Pu.1 binds sites within the DC-SIGN promoter as well as the HIV LTR and promotes transcription. The resulting elevated DC-SIGN
expression in DCs lead to maintenance an immature DC phenotype and thus increased HIV infectivity. By binding NF-kB sites within the LTR, PU.1
increases viral transcription and pathogenesis.
doi:10.1371/journal.pone.0083682.g006

media in the presence or absence of cocaine. Following a 2 day
exposure, we examined the expression of CD83, a DC maturation
marker. An increase in CD83 expression was observed upon DC
maturation in the absence of cocaine (Fig. 5C–D). However, in the
presence of cocaine CD83 expression was significantly reduced.
Furthermore, cells transfected with the miR-155 inhibitor also
exhibit reduced CD83 expression. No difference in CD83
expression was observed in cells transfected with the negative
control miRNA when compared to the untransfected control (data
not shown). Taken together, these results indicate that cocaine
impairs DC maturation through the down regulation of miR-155
expression. To rule out the possibility that transient transfection
could activate apoptosis or cause direct cell death we measured
cytotoxicity in MDDCs that were transfected with mimic miR-155
and infected with HIV-1 with/without cocaine treatment. The
results indicated that over-expression of miR-155 does not cause
cytotoxicity in MDDCs (Fig 5E), thus validating the observation of
cocaine induced modifications on miR-155 expression.

PLOS ONE | www.plosone.org

Discussion and Conclusion
Several investigators have previously demonstrated that cocaine
promotes HIV pathogenesis [4,31,41,42]. In HIV infection as well
as in other infections, MDDCs are the first line of defense and
have been suggested to be the initial target of infection
[4,31,43,44]. During maturation of human MDDCs, levels of
miR-155 increase [21,38] and once DCs become mature they are
less susceptible to HIV-1 infection [31]. Interestingly, miR-155 has
been associated with increased susceptibility to HIV-1 infection
[21]. The polycistronic miR-17/92 cluster, which encodes miR20a, is believed to play a physiological role in controlling HIV-1
replication [10]. We hypothesized that cocaine may affect miR155 levels and thus indirectly increase HIV susceptibility in
MDDCs. In this study, we examined the in vitro effect of cocaine on
miR-155 and 20a expression, and subsequent impact on HIV
transcription. We demonstrated that cocaine significantly reduced,
in a dose dependent manner, miR-155 and miR-20a genes in
MDDCs. Our results show that even the highest concentration of
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cocaine used (10 mM) was not cytotoxic to MDDCs, thus ruling
out the possibility of non-specific down-regulation of miRNAs.
It has been previously reported that DC-SIGN is reduced when
cells overexpress miR-155 [14,21,38] and that cocaine facilitates
neuropathogenesis of HIV-1 infection [4]. Our results suggest that
cocaine suppresses miR-155 expression; thereby, increasing DCSIGN expression on MDDCs, possibly preventing the maturation
of dendritic cells, and increasing susceptibility to HIV-1 infection.
This is the first report demonstrating that cocaine suppresses miR155 and miR20a. We show that HIV, similar to cocaine,
suppressed the miR-155 and miR-20a expression compared to
the uninfected control. Together HIV and cocaine synergistically
lowered miR-155 and miR-20a compared to HIV-1 or cocaine
alone. Consistent with previous studies [4] we show that cocaine
significantly enhances HIV-1 infection in MDDCs. Overexpression of miR-155 in MDDCs demonstrated reduced levels of HIV
LTR/R-U5 while inhibition of miR-155 enhanced LTR/R-U5
gene expression. This indicates that the MDDCs have become
more permissive to HIV infection in the absence of miR-155,
suggesting a role for miR-155 in HIV transcription. The presence
of cocaine further lowered miR-155 expression and exacerbated
the observed effect. Taken together, these results suggest that a
miR-155 mimic has the potential to reduce HIV-1 replication and
raises the possibility of targeting miR-155 as a novel therapeutic in
HIV-1 infected cocaine abusers.
Reduction of PU.1, one of the direct functional targets for miR155 [21,22,45], is associated with lowered DC-SIGN expression
during the maturation of MDDCs.[24]. Based on these previous
studies, we investigated the role of cocaine on miR-155 regulation
of PU.1 expression. We also found that cocaine up-regulated PU.1
expression and that this is mediated by the down-regulation of
miR-155. This effect may be attributed to cocaine-mediated
enhancement of HIV-1 pathogenesis, since increased PU.1 is
linked to elevated DC-SIGN [21]. We observed that HIV-1
decreased PU.1 levels rather than an increase in the levels, as
expected. This observation may be due to the fact that in HIV
infection multiple miRNAs may be differentially expressed thereby
limiting the overall effect on PU.1 expression. Previous studies
show that PU.1-deficient mice exhibit defective DC development
[46,47] suggesting that PU.1 is integral for DC development. PU.1
is likely to have multiple targets within DCs since it has already
been shown to regulate a large number of myeloid genes [48,49];
including DC-SIGN in myeloid cells [21].
Our study and previous reports suggest that miR-155 regulates
the DC-SIGN expression at the transcriptional level, via directly

targeting PU.1. The role of DC-SIGN in HIV infection and
regulation of DC-SIGN by miR-155 prompted us to examine the
role of miR-155 in HIV transcription and DC-SIGN expression. A
decrease in DC-SIGN was reported with the over-expression of
miR-155 [21]. Here, we show an increase in DC-SIGN with miR155 inhibition. Cocaine treatment also increased DC-SIGN,
which is in-line with our previous report. Further, miR-155 and
cocaine showed a synergistic effect on DC-SIGN expression. This
suggests that, increased DC-SIGN expression by cocaine is
mediated through miR-155 modulation.
During maturation of human MDDCs, levels of miR-155
increase [5,14,21] and DC-SIGN expression is lowered [50],
which is associated with a reduction of PU.1. Although there have
been conflicting studies, increased miR-155 upon TLR stimulation
is shown to up-regulate CD86, CD40, and IL12p40 [51]. In this
study, we found a reduction in the number of cells expressing
CD83 with miR-155 inhibition indicating reduced MDDCs
maturation. Cocaine also reduced CD83 on MDDCs. As DCs
become mature they are less susceptible to HIV-1 infection. This
suggests that cocaine-mediated suppression of miR-155 could
prevent the maturation of dendritic cells resulting in increased
DC-SIGN expression and susceptibility to HIV-1 infection.
Prevention of maturation may lead to poor antigen presentation,
poor immunogenicity, and increased HIV immune evasion.
In summary, we show for the first time that cocaine downregulates cellular miR-155 and 20a. Figure 6 summarizes an
overview of cocaine mediated enhancement of HIV infectivity in
MDC via the down-regulation of miR-155. Given the impact of
miR-155 in DC-SIGN expression and the role of miR-155 in DC
maturation, the down-regulation of miR-155 by cocaine suggest a
role for cocaine-mediated enhancement of HIV permissiveness in
MDDCs. Our results suggest that the mechanism of cocaine
mediated enhancement of HIV infection may be mediated by the
down-regulation of miR-155 and this could lead to faster
progression of HIV disease. Overall, results from our study could
potentially lead to the development of novel miRNA-based
therapeutic strategies targeting cocaine addiction and HIV
infection.
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